LEXINGTON, Mass., June 10, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the 'Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the grant on June 3, 2026, of 60,000 restricted stock units ('RSUs”) of the Company’s Class A common stock ('Common Stock”) as a material inducement to employment for a new employee. Such equity award was made under the Company’s Inducement Plan, as amended (the 'Inducement Plan”) and was approved by a majority of the independent directors of the Board of Directors or a duly authorized committee thereof in accordance with Nasdaq Listing Rule 5635(c)(4). The equity award is subject to the terms and conditions of the Inducement Plan, and the terms and conditions of the applicable RSU award agreement covering the grant.